Find Clinical Trials
Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg on request (maximum 5 times a day) on the top of L-dopa and a dopamine agonist in advanced Parkinson Disease patients with motor fluctuations: a 4-week open label pilot study
Servier Protocol Code:
SC3-90049-001
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2005-002010-38
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Parkinson's disease
- PIRIBEDIL
- S090049
Other study id numbers
Other identification numbers the study may be known by.
- SC3-90049-001